Cargando…
Cardiovascular Safety Pharmacology of Sibutramine
Sibutramine is an anorectic that has been banned since 2010 due to cardiovascular safety issues. However, counterfeit drugs or slimming products that include sibutramine are still available in the market. It has been reported that illegal sibutramine-contained pharmaceutical products induce cardiova...
Autores principales: | Yun, Jaesuk, Chung, Eunyong, Choi, Ki Hwan, Cho, Dae Hyun, Song, Yun Jeong, Han, Kyoung Moon, Cha, Hey Jin, Shin, Ji Soon, Seong, Won-Keun, Kim, Young-Hoon, Kim, Hyung Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489835/ https://www.ncbi.nlm.nih.gov/pubmed/26157557 http://dx.doi.org/10.4062/biomolther.2015.033 |
Ejemplares similares
-
Sibutramine on Cardiovascular Outcome
por: Scheen, André J.
Publicado: (2011) -
Measurement of Human Cytochrome P450 Enzyme Induction Based on Mesalazine and Mosapride Citrate Treatments Using a Luminescent Assay
por: Kim, Young-Hoon, et al.
Publicado: (2015) -
Phentermine, Sibutramine and Affective Disorders
por: An, Hoyoung, et al.
Publicado: (2013) -
Sibutramine-Induced Nonischemic Cardiomyopathy
por: Shah, Meet S, et al.
Publicado: (2022) -
Sibutramine (Reductil®)-Induced Cutaneous Leukocytoclastic Vasculitis: A Case Report
por: Ha, You Jin, et al.
Publicado: (2011)